Clinical Studies Sponsored by SIGA Technologies

Clinical Studies Sponsored by SIGA Technologies

Clinical Studies Sponsored by Akebia Therapeutics

Clinical Studies Sponsored by Harvard University

Clinical Studies Sponsored by Regeneron Pharmaceuticals

Cryptocurrencies

List of funding rounds for IMAGINEOPTIX CORP

Clinical Studies where

Trial Sponsor

is

	Name	Description	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
	‌ A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox		NCT03972111	Smallpox	January 1, 2020	September 30, 2024	Observational
	‌ Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders		NCT04485039	Smallpox	June 8, 2022	April 23, 2023	Interventional
	‌ Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers		NCT00431951	‌ Healthy	2007	2008	Interventional
	‌ Phase I Trial of an Investigational Small Pox Medication		NCT00728689	Smallpox	2008	2008	Interventional
	‌ Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG		NCT04392739	Smallpox	July 19, 2019	December 5, 2019	Interventional
	‌ A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat		NCT02474589	Smallpox	June 19, 2015	August 24, 2016	Interventional
	‌ Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Day		NCT04971109	Smallpox	March 29, 2022	May 12, 2023	Interventional
	‌ Study to Assess the Safety and Pharmacokinetics of TPOXX® When Administered Orally for 28 Days		NCT04957485	Smallpox	January 5, 2022	May 5, 2023	Interventional

8 results

0 selected

8 results

0 selected